NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The system consists of new features and capabilities, including a new touchscreen user interface and integrated blood pressure monitor designed to enhance ease of use for patients performing home hemodialysis.

The system is currently under review for 510(k) clearance from the U.S. Food and Drug Administration.

“Our next generation system was developed with extensive patient and customer feedback and builds on our decade long experience in providing life-changing therapy with the NxStage System One to over 30 thousand patients in their homes around the world,” said Joseph E. Turk, president of NxStage Medical, Inc. “We are very excited to expand our portfolio and begin providing patients with new features and capabilities that are designed to significantly improve their therapy experience.”